ReviewMolecular biology reports2026
Post-translational modifications: Principal regulators of bladder cancer.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder cancer (BCa) is among the most prevalent neoplasms of the urinary and reproductive systems, ranking ninth in overall cancer incidence. Existing treatment modalities have not yet achieved a reduction in the elevated incidence and fatality rates of BCa. Consequently, enhancing our comprehension of the molecular pathways involved in the onset and progression of BCa to formulate novel and successful therapeutic strategies is a prominent area of research. Post-translational modifications (PTMs), essential regulators of protein structure, function, and diverse biological processes, play pivotal roles in key oncogenic mechanisms in BCa. These mechanisms include tumor cell proliferation, development, metastasis, and, in particular, angiogenesis.This article explores the carcinogenic impacts of diverse PTMs on BCa and examines their prospective applications in the diagnosis and treatment of BCa.
Indexed as
Identifiers
41758403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.